BRIEF-Lilly, Astrazeneca to develop potentially disease-modifying Alzheimer's treatment
* Lilly and Astrazeneca to develop second potentially disease-modifying treatment for Alzheimer's disease
July 17 UnitedHealth Group Inc, the largest U.S. health insurer, reported a 7 percent rise in quarterly revenue, helped by the addition of 270,000 members to its healthcare plans and strong growth in its Optum pharmacy services division.
Net income was $1.41 billion, or $1.42 per share, in the second-quarter ended June 30, compared to $1.44 billion, or $1.40 per share, a year earlier.
Total revenues rose to $32.6 billion from $30.4 billion. (Reporting by Shailesh Kuber; Editing by Sriraj Kalluvila)
Dec 9 U.S. stock index futures edged up on Friday, indicating that investors were still eager to buy into the post-election rally that has propelled a host of Wall Street indexes to record highs.
* Lee enterprises inc- "expect to continue to use substantially all our free cash flow to reduce debt in fiscal 2017"